Bank of America
MPLT

Bank of America’s MapLight Therapeutics MPLT Stock Holding History

Bank of America’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95M Buy
54,464
+35,595
+189% +$1.02M ﹤0.01% 4221
2026
Q1 		$384K Sell
18,869
-18,951
-50% -$339K ﹤0.01% 5033
2025
Q4 		$664K Buy
+37,820
New +$634K ﹤0.01% 4753

Other funds holding MPLT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America's MPLT Position: Q2 2026 in Review

Bank of America increased its MapLight Therapeutics (MPLT) stake by 189% in Q2 2026, buying an estimated $1.02M and bringing the position to 54,464 shares worth $1.95M. The position accounts for ﹤0.01% of the portfolio, ranked #4221.

Bank of America first reported a position in MPLT in Q4 2025 and has held it in 3 quarters since. 105 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • Bank of America held 54,464 shares of MapLight Therapeutics worth $1.95M as of Q2 2026.
  • Bank of America bought 35,595 MapLight Therapeutics shares in Q2 2026, an estimated $1.02M.
  • MapLight Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4221 holding.
  • Bank of America first reported a position in MapLight Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 105 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.